Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer

NCT02194049 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: BKM120
DRUG: cisplatin
DRUG: etoposide

Sponsor

University of California, Davis

Collaborators

[object Object]